Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | hypothetical protein | 0.0481 | 0.0175 | 0.0185 |
Echinococcus granulosus | tissue type plasminogen activator | 0.1639 | 0.5385 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0481 | 0.0175 | 0.0185 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0539 | 0.0437 | 0.0267 |
Brugia malayi | Trypsin family protein | 0.0481 | 0.0175 | 0.0185 |
Brugia malayi | Trypsin-like protease protein 5 | 0.0481 | 0.0175 | 0.0185 |
Toxoplasma gondii | PAN domain-containing protein | 0.1025 | 0.2621 | 0.4868 |
Echinococcus granulosus | Mastin | 0.0602 | 0.072 | 0.1046 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.1639 | 0.5385 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.1639 | 0.5385 | 0.5679 |
Leishmania major | hypothetical protein, conserved | 0.1639 | 0.5385 | 0.5 |
Onchocerca volvulus | 0.1639 | 0.5385 | 0.5679 | |
Loa Loa (eye worm) | hypothetical protein | 0.0481 | 0.0175 | 0.0185 |
Onchocerca volvulus | 0.0481 | 0.0175 | 0.0185 | |
Brugia malayi | Kringle domain containing protein | 0.1639 | 0.5385 | 0.5679 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0602 | 0.072 | 0.0554 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.1639 | 0.5385 | 0.5679 |
Onchocerca volvulus | 0.0481 | 0.0175 | 0.0185 | |
Loa Loa (eye worm) | trypsin family protein | 0.0481 | 0.0175 | 0.0185 |
Loa Loa (eye worm) | hypothetical protein | 0.0481 | 0.0175 | 0.0185 |
Echinococcus multilocularis | glycoprotein Antigen 5 | 0.0602 | 0.072 | 0.1046 |
Echinococcus granulosus | enteropeptidase | 0.0602 | 0.072 | 0.1046 |
Loa Loa (eye worm) | hypothetical protein | 0.0481 | 0.0175 | 0.0185 |
Schistosoma mansoni | hypothetical protein | 0.1639 | 0.5385 | 0.5302 |
Loa Loa (eye worm) | hypothetical protein | 0.0481 | 0.0175 | 0.0185 |
Echinococcus multilocularis | Mastin | 0.0602 | 0.072 | 0.1046 |
Onchocerca volvulus | 0.0481 | 0.0175 | 0.0185 | |
Brugia malayi | Chymotrypsin-like protease CTRL-1 precursor | 0.0481 | 0.0175 | 0.0185 |
Echinococcus granulosus | glycoprotein Antigen 5 | 0.0602 | 0.072 | 0.1046 |
Toxoplasma gondii | PAN domain-containing protein | 0.1025 | 0.2621 | 0.4868 |
Brugia malayi | Trypsin family protein | 0.255 | 0.9482 | 1 |
Onchocerca volvulus | 0.0481 | 0.0175 | 0.0185 | |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.1639 | 0.5385 | 0.5 |
Toxoplasma gondii | kringle domain-containing protein | 0.1639 | 0.5385 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1639 | 0.5385 | 0.5679 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.1639 | 0.5385 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0481 | 0.0175 | 0.5 |
Onchocerca volvulus | 0.255 | 0.9482 | 1 | |
Onchocerca volvulus | 0.0481 | 0.0175 | 0.0185 | |
Loa Loa (eye worm) | hypothetical protein | 0.255 | 0.9482 | 1 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.1639 | 0.5385 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.255 | 0.9482 | 1 |
Brugia malayi | Trypsin family protein | 0.0481 | 0.0175 | 0.0185 |
Brugia malayi | Trypsin family protein | 0.0481 | 0.0175 | 0.0185 |
Echinococcus multilocularis | enteropeptidase | 0.0602 | 0.072 | 0.1046 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.255 | 0.9482 | 0.9473 |
Onchocerca volvulus | 0.2069 | 0.732 | 0.772 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 0 % | Inhibition of slow reacting substance of anaphylaxis (SRS-A) release from sensitized guinea pig chopped lung upon antigen challenge at 10 ug/mL | ChEMBL. | 3612683 |
Inhibition (functional) | NT 0 % | Inhibition of histamine release from sensitized guinea pig chopped lung, upon antigen challenge at 10 ug/mL. | ChEMBL. | 3612683 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.